25 May 2013
Keywords: pfizer, announces, uk, launch, macugen, treatment, wet
Article | 29 May 2006
US pharmaceutical behemoth Pfizer has announced the UK launch of its wet age-related macular degeneration treatment, Macugen (pegaptanib sodium).
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
29 May 2006
24 May 2013
© 2013 thepharmaletter.com